Skip to main content

Medicare & Medicaid

By Susan Morse | 11:30 am | January 04, 2024
Rebates bring down prices by as much as half.
By Susan Morse | 11:06 am | January 03, 2024
A corrective action process would allow providers to rectify conduct without dissuading them from participating in Medicare, MGMA says. 
By Susan Morse | 01:40 pm | December 29, 2023
Humana opposes the transfer to the Dallas division, DOJ says.
By Nathan Eddy | 09:52 am | December 28, 2023
More than half of Medicare's 66 million beneficiaries are opting for a MA plan, which is likely to further strain the health system.
By Jeff Lagasse | 10:26 am | December 21, 2023
The purchase price for the transaction, net of certain tax benefits, is reduced from $510 million to approximately $425 million.
By Jeff Lagasse | 01:51 pm | December 19, 2023
The lawsuit accuses Humana of cutting payments prematurely for rehabilitative care based on its AI model's "highly inaccurate" recovery predictions.
By Jeff Lagasse | 11:06 am | December 19, 2023
Of the roughly 1.1 million enrollees who have opioid use disorder, just 18% receive medication to treat it, OIG said.
By Susan Morse | 11:02 am | December 19, 2023
The Federal IDR process is used when plans and providers cannot agree on the payment amount for out-of-network items and services.
By Susan Morse | 07:38 pm | December 14, 2023
HHS also released the names of the first 10 drugs under Part D selected for Medicare drug price negotiations.
By Jeff Lagasse | 10:53 am | December 13, 2023
The group said high levels of market concentration is leaving millions of Americans with limited competitive options for health insurance.